Examining the Knowledge, Attitudes, and Beliefs of Sickle Cell Disease Patients, Parents of Patients With Sickle Cell Disease, and Providers Towards the Integration of CRISPR in Clinical Care
CompletedOBSERVATIONAL
Enrollment
109
Participants
Timeline
Start Date
April 28, 2017
Primary Completion Date
December 31, 2017
Study Completion Date
February 5, 2021
Conditions
Sickle Cell Disease
Trial Locations (1)
20892
National Human Genome Research Institute (NHGRI), Bethesda
All Listed Sponsors
lead
National Human Genome Research Institute (NHGRI)
NIH
NCT03167450 - Examining the Knowledge, Attitudes, and Beliefs of Sickle Cell Disease Patients, Parents of Patients With Sickle Cell Disease, and Providers Towards the Integration of CRISPR in Clinical Care | Biotech Hunter | Biotech Hunter